Search Results
Community Conversation: AMX0035 in the FDA’s Approval Process
Community Conversation with Amylyx
AMX0035 Research Update 19OCT20
WEBINAR: AMX0035 Results - Implications for People with ALS
Amylyx receives the 2021 Essey Commitment to Cures Award
ALS FDA Session
Community Conversation - Influencing ALS research at NIH
NEWS: AMLX Posts FDA Documents On AMX0035
March 30, 2022
Congressional Hearing with the FDA- Representative Schakowsky
Treatment updates in ALS: edaravone, AMX0035, and tofersen
MIROCALS: low-dosage IL-2 for the treatment of ALS
